Blog

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Nineteen of PNI’s doctors have been recognized as Super Doctors in the 2021 announcement of this prestigious industry standard award. Of note, Daniel F. Kelly, MD, Founder and Director of PNI, and expert neurosurgeon became a Hall of Fame Super Doctor. With his selection to...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

U.S. News & World Report highlights quality, specialty care Ten Providence Southern California hospitals and affiliated partners in Los Angeles and Orange counties earned recognition on July 28, 2020, from U.S. News & World Report. With approximately 415 acute care hospitals in California, the 10...

Find out about the new and ongoing neuroscience clinical trials at Pacific Neuroscience Institute, addressing difficult diseases such as brain tumors.

July 22, 2020 is Glioblastoma Awareness Day. Glioblastoma (GBM) is one of the most notorious forms of brain cancer and one of the most challenging malignancies to treat in all of oncology.

In the field of neurosurgery, Daniel F. Kelly, MD, is loved by his patients and esteemed by his colleagues. Soft spoken and eloquent, he has a quiet confidence that underscores this highly skilled neurosurgeon’s drive, determination and focus in always pushing the boundaries of excellence....